Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HTK versus hypothermic hyperkalemic blood for myocardial protection in acyanotic congenital heart surgery
PACTR202109777317416Completed
- Sponsor
- Ain Shams University Faculty of Medicine
- Start
- Feb 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label trial of HTK Custodiol in Cardiovascular Malformation (CVM) (2 arms), sponsored by Ain Shams University Faculty of Medicine. Primary endpoint: Troponin level. Started Feb 2020; status: completed.
02
Drugs
HTK Custodiol
03
Conditions
Cardiovascular Malformation (CVM)
Beyond the preview
Go deeper on PACTR202109777317416.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202109777317416.